Format

Send to

Choose Destination
Nat Rev Urol. 2018 Oct;15(10):585-587. doi: 10.1038/s41585-018-0056-3.

Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma.

Author information

1
Barts Cancer Institute Experimental Medicine Centre, Queen Mary University of London St Bartholomew's Hospital, London, UK. Thomas.Powles@bartshealth.nhs.uk.
2
Barts Cancer Institute Experimental Medicine Centre, Queen Mary University of London St Bartholomew's Hospital, London, UK.
PMID:
30030491
DOI:
10.1038/s41585-018-0056-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center